Status:
RECRUITING
Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes
Lead Sponsor:
Elizabeth Pfoh
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Blood Pressure Control
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The vast majority of the 36.2 million individuals admitted to U.S. hospitals are diagnosed with hypertension and experience an elevated blood pressure (BP) reading during hospitalization. There are no...
Detailed Description
Approximately 50-72% of the 36.2 million individuals admitted to U.S. hospitals are diagnosed with hypertension. Hypertension increases the risk of devastating cardiovascular outcomes, such as strokes...
Eligibility Criteria
Inclusion
- At the unit level: Medical units that do not typically care for patients requiring step-down care.
Exclusion
- Patients less than 18
- Patients experiencing hypertensive emergencies or cardiac symptoms
- Patients with active cardiovascular events, such as
- Stroke
- Non-ST-elevation
- Myocardial infarction
- End-stage renal disease
- Patients on dialysis
- Those with acute decompensated heart failure
- 3\. Patients on the unit for more than 10 days
- 4\. Patients transferred in after being in the intensive care unit (ICU)
- 5\. Pregnant and post-partum women
- 6\. Patients discharged within 24 hours of admission
- 7\. Patients whose systolic BP remains below 160 mmHg during hospitalization.
Key Trial Info
Start Date :
November 11 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2027
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT07208669
Start Date
November 11 2025
End Date
July 31 2027
Last Update
January 8 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Main Campus
Cleveland, Ohio, United States, 44195
2
Cleveland Clinic Hillcrest
Mayfield Heights, Ohio, United States, 44124